Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum-Reference-Cited by-同舟云学术

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

Published:2019-03-07 Issue:5 Volume:15 Page:644-654
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Bos Isabelle¹,Vos Stephanie¹,Verhey Frans¹,Scheltens Philip²,Teunissen Charlotte³,Engelborghs Sebastiaan⁴⁵⁶,Sleegers Kristel⁶⁷,Frisoni Giovanni⁸⁹,Blin Olivier¹⁰,Richardson Jill C.¹¹,Bordet Régis¹²,Tsolaki Magda¹³,Popp Julius¹⁴¹⁵,Peyratout Gwendoline¹⁵,Martinez‐Lage Pablo¹⁶,Tainta Mikel¹⁶,Lleó Alberto¹⁷,Johannsen Peter¹⁸,Freund‐Levi Yvonne¹⁹²⁰²¹,Frölich Lutz²²,Vandenberghe Rik²³,Westwood Sarah²⁴,Dobricic Valerija²⁵,Barkhof Frederik²⁶²⁷,Legido‐Quigley Cristina²⁸²⁹,Bertram Lars²⁵³⁰³¹,Lovestone Simon²⁴,Streffer Johannes⁵³²,Andreasson Ulf³³³⁴,Blennow Kaj³³³⁴,Zetterberg Henrik³³³⁴³⁵³⁶,Visser Pieter Jelle¹²

Affiliation:

1. Alzheimer Centrum LimburgMaastricht UniversityMaastrichtthe Netherlands

2. Alzheimer CenterVU University Medical CenterAmsterdamthe Netherlands

3. Neurochemistry Lab and BiobankDepartment of Clinical ChemistryVU University Medical CenterAmsterdam NeuroscienceAmsterdamthe Netherlands

4. Department of Neurology and Memory ClinicHospital Network Antwerp (ZNA) Middelheim and Hoge BeukenAntwerpBelgium

5. Reference Center for Biological Markers of Dementia (BIODEM)Institute Born‐BungeUniversity of AntwerpAntwerpBelgium

6. Institute Born‐BungeUniversity of AntwerpAntwerpBelgium

7. Neurodegenerative Brain Diseases GroupCenter for Molecular NeurologyVIBAntwerpBelgium

8. University of GenevaGenevaSwitzerland

9. IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliBresciaItaly

10. Mediterranean Institute of Cognitive NeuroscienceAix Marseille UniversityMarseilleFrance

11. Neurosciences Therapeutic AreaGlaxoSmithKline R&DStevenageUK

12. University of LilleInsermCHU LilleLilleFrance

13. 1st Department of NeurologyAHEPA University HospitalMakedoniaThessalonikiGreece

14. Geriatric PsychiatryDepartment of Mental Health and PsychiatryGeneva University HospitalsGenevaSwitzerland

15. Department of PsychiatryUniversity Hospital of LausanneLausanneSwitzerland

16. Department of NeurologyCenter for Research and Advanced TherapiesCITA‐Alzheimer FoundationSan SebastianSpain

17. Hospital de la Santa Creu i Sant PauBarcelonaSpain

18. Danish Dementia Research CentreRigshospitaletCopenhagen University HospitalCopenhagenDenmark

19. Department of NeurobiologyCaring Sciences and Society (NVS)Division of Clinical GeriatricsKarolinska InstitutetStockholmSweden

20. Department of Geriatric MedicineKarolinska University Hospital HuddingeStockholmSweden

21. Department of Psychiatry Norrtälje Hospital TiohundraNorrtäijeSweden

22. Department of Geriatric PsychiatryZentralinstitut für Seelische GesundheitUniversity of HeidelbergMannheimGermany

23. University Hospital LeuvenLeuvenBelgium

24. University of OxfordOxfordUnited Kingdom

25. Lübeck Interdisciplinary Platform for Genome AnalyticsUniversity of LübeckLübeckGermany

26. Department of Radiology and Nuclear MedicineVU University Medical CenterAmsterdamthe Netherlands

27. Institutes of Neurology and Healthcare EngineeringUniversity College LondonLondonUK

28. Steno Diabetes CenterCopenhagenDenmark

29. King's College LondonLondonUK

30. School of Public HealthImperial College LondonLondonUK

31. Department of PsychologyUniversity of OsloOsloNorway

32. Early Clinial NeurologyUCB Biopharma SPRLBraine‐l'AlleudBelgium

33. Clinical Neurochemistry LabInstitute of Neuroscience and PhysiologySahlgrenska University HospitalMölndalSweden

34. Department of Psychiatry and NeurochemistryUniversity of GothenburgInstitute of Neuroscience and PhysiologyMölndalSweden

35. Department of Molecular NeuroscienceUCL Institute of NeurologyLondonUK

36. UK Dementia Research InstituteLondonUK

Funder

European Commission

Roche

Probiodrug

Janssen Prevention Center

Boehringer

Brains Online

Axon Neurosciences

EIP Pharma

Innovative Medicines Initiative

Seventh Framework Program

EFPIA

Department of Health of the Basque Government

Swiss National Research Foundation

University of Antwerp Research Fund

NIHR UCLH biomedical research center

Department of Economic Promotion, Rural Areas and Territorial Balance of the Provincial Government of Gipuzkoa

Department of Health of the Basque Government

Carlos III Institute of Health

Obra Social Kutxa-Fundazioa

Dutch Research Council (ZonMW)

Alzheimer's Drug Discovery Foundation

Alzheimer Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2019.01.004

Reference43 articles.

1. Applying fluid biomarkers to Alzheimer's disease

2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Amyloid biomarkers in Alzheimer's disease

4. Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease

5. tau protein in cerebrospinal fluid

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer’s Disease or Other Neurological Diseases;Journal of Alzheimer's Disease;2023-12-06

2. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain;Acta Neuropathologica Communications;2023-11-14

3. Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia;Annals of Neurology;2023-11-10

4. Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer’s disease;Expert Review of Molecular Diagnostics;2023-11-03

5. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis;Ageing Research Reviews;2023-11